| Literature DB >> 36264505 |
Yassine Bouchoucha1,2, Thomas Kergrohen3, Alice Métais4,5, Volodia Dangouloff-Ros6, Xavier Maynadier7, Yassine Ajlil3, Matthieu Carton7, Wael Yacoub6, Raphael Saffroy8, Dominique Figarella-Branger9, Emmanuelle Uro-Coste10, Annick Sevely11, Delphine Larrieu-Ciron12,13, Maxime Faisant14, Marie-Christine Machet15, Ellen Wahler16, Alexandre Roux17,18, Sandro Benichi19, Kevin Beccaria19, Thomas Blauwblomme19, Nathalie Boddaert6, Fabrice Chrétien16, François Doz1,2, Christelle Dufour20, Jacques Grill20, Marie Anne Debily3,21, Pascale Varlet16,17, Arnault Tauziède-Espariat16,17.
Abstract
Pediatric spinal low-grade glioma (LGG) and glioneuronal tumours are rare, accounting for less 2.8-5.2% of pediatric LGG. New tumour types frequently found in spinal location such as diffuse leptomeningeal glioneuronal tumours (DLGNT) have been added to the World Health Organization (WHO) classification of tumours of the central nervous system since 2016, but their distinction from others gliomas and particularly from pilocytic astrocytoma (PA) are poorly defined. Most large studies on this subject were published before the era of the molecular diagnosis and did not address the differential diagnosis between PAs and DLGNTs in this peculiar location. Our study retrospectively examined a cohort of 28 children with LGGs and glioneuronal intramedullary tumours using detailed radiological, clinico-pathological and molecular analysis. 25% of spinal PAs were reclassified as DLGNTs. PA and DLGNT are nearly indistinguishable in histopathology or neuroradiology. 83% of spinal DLGNTs presented first without leptomeningeal contrast enhancement. Unsupervised t-distributed stochastic neighbor embedding (t-SNE) analysis of DNA methylation profiles showed that spinal PAs formed a unique methylation cluster distinct from reference midline and posterior fossa PAs, whereas spinal DLGNTs clustered with reference DLGNT cohort. FGFR1 alterations were found in 36% of spinal tumours and were restricted to PAs. Spinal PAs affected significantly younger patients (median age 2 years old) than DLGNTs (median age 8.2 years old). Progression-free survival was similar among the two groups. In this location, histopathology and radiology are of limited interest, but molecular data (methyloma, 1p and FGFR1 status) represent important tools differentiating these two mitogen-activated protein kinase (MAPK) altered tumour types, PA and DLGNT. Thus, these molecular alterations should systematically be explored in this type of tumour in a spinal location.Entities:
Keywords: Diffuse leptomeningeal glioneuronal tumour; Glioneuronal tumour; Intramedullary glioma; Methylation profiling; Pediatric low-grade glioma; Pilocytic astrocytoma
Year: 2022 PMID: 36264505 PMCID: PMC9582396 DOI: 10.1007/s00401-022-02512-6
Source DB: PubMed Journal: Acta Neuropathol ISSN: 0001-6322 Impact factor: 15.887